Elanco Animal Health Financial Statements (ELAN)
|
|
|
|
Report date
|
|
|
28.02.2020 |
01.03.2021 |
28.02.2022 |
01.03.2023 |
26.02.2024 |
|
07.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
3 071 |
3 273 |
4 765 |
4 418 |
4 417 |
|
4 454 |
|
Operating Income, bln rub |
|
|
342.6 |
101.5 |
297.0 |
358.0 |
326.0 |
|
219.0 |
|
EBITDA, bln rub |
? |
|
471.6 |
-76.8 |
409.0 |
866.0 |
-224.0 |
|
600.0 |
|
Net profit, bln rub |
? |
|
67.9 |
-560.1 |
-472.0 |
-74.0 |
-1 231 |
|
205.0 |
|
|
OCF, bln rub |
? |
|
224.1 |
-41.0 |
483.0 |
452.0 |
271.0 |
|
521.0 |
|
CAPEX, bln rub |
? |
|
197.4 |
310.9 |
197.0 |
184.0 |
154.0 |
|
141.0 |
|
FCF, bln rub |
? |
|
26.7 |
-351.9 |
286.0 |
268.0 |
117.0 |
|
380.0 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 231 |
1 684 |
2 329 |
2 115 |
1 612 |
|
1 919 |
|
Cost of production, bln rub |
|
|
1 470 |
1 667 |
2 134 |
1 913 |
1 931 |
|
2 282 |
|
R&D, bln rub |
|
|
270.1 |
327.0 |
369.0 |
321.0 |
327.0 |
|
342.0 |
|
Interest expenses, bln rub |
|
|
78.9 |
149.8 |
236.0 |
241.0 |
277.0 |
|
256.0 |
|
|
Assets, bln rub |
|
|
8 986 |
17 693 |
16 483 |
15 491 |
14 362 |
|
13 283 |
|
Net Assets, bln rub |
? |
|
5 547 |
8 476 |
7 538 |
7 289 |
6 223 |
|
6 523 |
|
Debt, bln rub |
|
|
2 355 |
6 127 |
6 319 |
5 836 |
5 774 |
|
4 357 |
|
Cash, bln rub |
|
|
334.0 |
494.7 |
638.0 |
345.0 |
352.0 |
|
490.0 |
|
Net debt, bln rub |
|
|
2 021 |
5 632 |
5 681 |
5 491 |
5 422 |
|
3 867 |
|
|
Ordinary share price, rub |
|
|
29.5 |
30.7 |
28.4 |
12.2 |
14.9 |
|
9.38 |
|
Number of ordinary shares, mln |
|
|
369.0 |
441.4 |
487.2 |
488.3 |
492.3 |
|
494.3 |
|
|
Market cap, bln rub |
|
|
10 867 |
13 538 |
13 827 |
5 967 |
7 335 |
|
4 637 |
|
EV, bln rub |
? |
|
12 888 |
19 170 |
19 508 |
11 458 |
12 757 |
|
8 504 |
|
Book value, bln rub |
|
|
75 |
-4 136 |
-4 221 |
-3 546 |
-3 365 |
|
-2 113 |
|
|
EPS, rub |
? |
|
0.18 |
-1.27 |
-0.97 |
-0.15 |
-2.50 |
|
0.41 |
|
FCF/share, rub |
|
|
0.07 |
-0.80 |
0.59 |
0.55 |
0.24 |
|
0.77 |
|
BV/share, rub |
|
|
0.20 |
-9.37 |
-8.66 |
-7.26 |
-6.84 |
|
-4.27 |
|
|
EBITDA margin, % |
? |
|
15.4% |
-2.35% |
8.58% |
19.6% |
-5.07% |
|
13.5% |
|
Net margin, % |
? |
|
2.21% |
-17.1% |
-9.91% |
-1.67% |
-27.9% |
|
4.60% |
|
FCF yield, % |
? |
|
0.25% |
-2.60% |
2.07% |
4.49% |
1.60% |
|
8.20% |
|
ROE, % |
? |
|
1.22% |
-6.61% |
-6.26% |
-1.02% |
-19.8% |
|
3.14% |
|
ROA, % |
? |
|
0.76% |
-3.17% |
-2.86% |
-0.48% |
-8.57% |
|
1.54% |
|
|
P/E |
? |
|
160.0 |
-24.2 |
-29.3 |
-80.6 |
-5.96 |
|
22.6 |
|
P/FCF |
|
|
407.0 |
-38.5 |
48.3 |
22.3 |
62.7 |
|
12.2 |
|
P/S |
? |
|
3.54 |
4.14 |
2.90 |
1.35 |
1.66 |
|
1.04 |
|
P/BV |
? |
|
145.9 |
-3.27 |
-3.28 |
-1.68 |
-2.18 |
|
-2.19 |
|
EV/EBITDA |
? |
|
27.3 |
-249.6 |
47.7 |
13.2 |
-57.0 |
|
14.2 |
|
Debt/EBITDA |
|
|
4.29 |
-73.3 |
13.9 |
6.34 |
-24.2 |
|
6.45 |
|
|
R&D/CAPEX, % |
|
|
136.8% |
105.2% |
187.3% |
174.5% |
212.3% |
|
242.6% |
|
|
CAPEX/Revenue, % |
|
|
6.43% |
9.50% |
4.13% |
4.16% |
3.49% |
|
3.17% |
|
| Elanco Animal Health shareholders |
